Preprint DKFZ-2026-01504

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Data-adaptive gene and pathway-based tests forrare-variant associations with survival outcomes

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
arXiv

Abstract: Statistical methods for testing aggregate rare-variant genetic associations are typically based on either burden or dispersion tests (or a combination of the two). These methods lack statistical power in the presence of diverse genetic architectures. Moreover, few aggregate rare-variant association methods have been developed specifically for survival data. To address these issues, we propose data-adaptive gene- and pathway-based association tests based on Schoenfeld residuals in Cox proportional hazards models for association studies between an aggregate of rare-variants and survival outcomes. Our methods improve statistical power while maintaining flexibility across various genetic effect sizes and directions. We develop an efficient R package that enables fast computation and supports data simulation as well as gene- and pathway-level testing. Applying our approach to late bladder toxicity following radiotherapy for non-metastatic prostate cancer, we identify biologically relevant genes and pathways, replicate known signals, and capture additional associations. Our method provides a powerful, adaptive framework for survival-based genetic association studies of rare-variants. Keywords: aSPU, time-to-event outcomes, rare-variant associations, Cox regression, Schoenfeld residuals

Keyword(s): Methodology (stat.ME) ; FOS: Computer and information sciences


Note: SCOPUS

Contributing Institute(s):
  1. Personalisierte Früherkennung des Prostatakarzinoms (C130)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Click to display QR Code for this record

The record appears in these collections:
Document types > Reports > Preprints
Public records
Publications database

 Record created 2026-06-22, last modified 2026-06-23



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)